Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fontanet

Showing results (461-470 of 505) with videos related to

Pageof 51
Sort By:
Plos One|March 8, 2013
Frequent transient hepatitis C viremia without seroconversion among healthcare workers in Cairo, EgyptAline Munier, Diaa Marzouk, Florence Abravanel, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 3, 2025
Implementation of the precision oncology program in catalonia's public health system: results, lessons learned, and future prospectsPilar Mur, Anna Pozuelo, Josep Tabernero, et al.
Eclinicalmedicine|July 27, 2022
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort studyTimothée Bruel, Laurie Pinaud, Laura Tondeur, et al.
Blood|December 22, 2021
Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA studyEmmanuel Bachy, Roch Houot, Pierre Feugier, et al.
Ejhaem|July 18, 2022
Phase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphomaLoretta J Nastoupil, John Kuruvilla, Julio C Chavez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 13, 2005
Polymorphism of RANTES chemokine gene promoter is not associated with long-term nonprogressive HIV-1 infection of more than 16 yearsFrancesc Vidal, Joaquim Peraire, Pere Domingo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2021
Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or OlderLucie Oberic, Frederic Peyrade, Mathieu Puyade, et al.
The American Journal of Tropical Medicine and Hygiene|April 11, 2020
Factors Influencing Atypical Clinical Presentations during the 2017 Madagascar Pneumonic Plague Outbreak: A Prospective Cohort StudyAlex P Salam, Mihaja Raberahona, Prisca Andriantsalama, et al.
Lancet (London, England)|March 8, 2016
Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control studyVan-Mai Cao-Lormeau, Alexandre Blake, Sandrine Mons, et al.
Blood Advances|December 8, 2022
Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA groupRaphaelle Aubrais, Krimo Bouabdallah, Loic Chartier, et al.
Pageof 51

Showing results (461-470 of 505) with videos related to

Sort By:
Pageof 51
Plos One|March 8, 2013
Frequent transient hepatitis C viremia without seroconversion among healthcare workers in Cairo, EgyptAline Munier, Diaa Marzouk, Florence Abravanel, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 3, 2025
Implementation of the precision oncology program in catalonia's public health system: results, lessons learned, and future prospectsPilar Mur, Anna Pozuelo, Josep Tabernero, et al.
Eclinicalmedicine|July 27, 2022
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort studyTimothée Bruel, Laurie Pinaud, Laura Tondeur, et al.
Blood|December 22, 2021
Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA studyEmmanuel Bachy, Roch Houot, Pierre Feugier, et al.
Ejhaem|July 18, 2022
Phase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphomaLoretta J Nastoupil, John Kuruvilla, Julio C Chavez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 13, 2005
Polymorphism of RANTES chemokine gene promoter is not associated with long-term nonprogressive HIV-1 infection of more than 16 yearsFrancesc Vidal, Joaquim Peraire, Pere Domingo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2021
Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or OlderLucie Oberic, Frederic Peyrade, Mathieu Puyade, et al.
The American Journal of Tropical Medicine and Hygiene|April 11, 2020
Factors Influencing Atypical Clinical Presentations during the 2017 Madagascar Pneumonic Plague Outbreak: A Prospective Cohort StudyAlex P Salam, Mihaja Raberahona, Prisca Andriantsalama, et al.
Lancet (London, England)|March 8, 2016
Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control studyVan-Mai Cao-Lormeau, Alexandre Blake, Sandrine Mons, et al.
Blood Advances|December 8, 2022
Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA groupRaphaelle Aubrais, Krimo Bouabdallah, Loic Chartier, et al.
Pageof 51